The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.
Prostate cancer is the leading cancer in BC men and the second leading cause of cancer deaths. By understanding the reasons for treatment resistance in advanced prostate cancer and translating that into new products and treatments, the Vancouver Prostate Centre is focused on improving longevity and quality of life for patients in BC, and around the world.
Campus
Vancouver
Open Research Positions
This list of possible research projects is non-exhaustive. It only shows positions that are specifically advertised in the G+PS website.
Affiliated UBC Faculty & Postdocs
| Name | Role | Research Interests |
|---|---|---|
| Abolmaesumi, Purang | Faculty (G+PS eligible/member) | Electrical engineering, computer engineering, and information engineering; Medical and biomedical engineering; Artificial Intelligence; Biomedical Engineering; Biomedical Technologies; Cancer Imaging; Computer Assisted Interventions; Image Guided Surgery; Machine Learning; Medical Imaging; Surgical Robotics; Ultrasound Imaging |
| Aparicio, Samuel | Faculty (G+PS eligible/member) | Breast cancer, genome sequencing |
| Bally, Marcel Bertran | Faculty (G+PS eligible/member) | Pancreas centre |
| Black, Peter | Faculty (G+PS eligible/member) | Canadian Charter of Rights and Freedoms (especially equality rights); Canadian human rights legislation |
| Cherkasov, Artem | Faculty (G+PS eligible/member) | Drug design; Bioinformatics, Molecular modeling; Proteomics; Artificial intelligence; Antibiotics |
| Chew, Ben | Faculty (G+PS eligible/member) | how kidney stones form and in particular intestinal absorption of minerals that can form kidney stones (calcium and oxalate); genetically modifying bacteria normally used to make yogurt to express a naturally occurring enzyme that breaks down oxalate, thus preventing its absorption into the body where it can combine with calcium to form kidney stones. |
| Chi, Kim Nguyen | Faculty (G+PS eligible/member) | Thrombosis in cancer patients, methemoglobinemia, hemolysis, anticancer drugs, prostate cancer, chemotherapy, cell cancer, breast cancer |
| Collins, Colin | Faculty (G+PS eligible/member) | translational genomics where mathematics, genomics, computer science, and clinical science converge in diagnostics and therapeutics |
| Cox, Michael | Faculty (G+PS eligible/member) | genetic testing, experiences of hereditary risk, social and ethical implications of genetics, interpersonal and family communication, qualitative research, narrative and story, Prostate cancer |
| Daugaard, Mads | Faculty (G+PS eligible/member) | Cancer progression and metastasis; Mechanisms of carcinogenesis; Cancer Diagnosis and Detection; Cancer biology; Cancer diagnostics; Cancer therapy; Cell Signaling and Cancer; Cell Therapy of Cancer; Chemotherapy; DNA damage response pathways; glycobiology; Immunotherapy; Radiotherapy; Cell stress and Cancer; Cell stress signalling in cancer |
| Dedhar, Shoukat | Faculty (G+PS eligible/member) | molecular biology, molecular biology as it relates to disease; developing new theraputics for cancer; how brain cells (neurons)make connections, therapeutics for cancer; molecular genetics and cancer; medical research, cancer, inflammatory diseases, cariovascular diseases, Cellular proteins, extracellular martrix, integrins, signal transduction, calreticulin, protein kinase, gene expression, cell differentiation |
| Dong, Xuesen | Faculty (G+PS eligible/member) | Cancer progression and metastasis; Gene and molecular therapy; Prostate Cancer; Drug development; RNA splicing and Gene Regulation; Hormone Dependent Cancers; Endocrine Regulation |
| Flannigan, Ryan | Faculty (G+PS eligible/member) | evaluating genetic and molecular mechanisms contributing to non-obstructive azoospermia (NOA) |
| Forbes, Connor | Faculty (G+PS eligible/member) | Urology; Other basic medicine and life sciences; Drug discovery, design and delivery; Endourology; Minimally Invasive Surgery; Benign Prostatic Hyperplasia; Kidney stones; Translational research |
| Gleave, Martin | Faculty (G+PS eligible/member) | Infectious diseases, interdisciplinary oncology, prostate |
| Goldenberg, S Larry | Faculty (G+PS eligible/member) | prostate cancer, men’s health issues |
| Hach, Faraz | Faculty (G+PS eligible/member) | Cancer; Algorithms and computational genomics; Computational Genomics; biomolecular sequence analysis |
| Jefferies, Wilfred Arthur | Faculty (G+PS eligible/member) | Iron transport molecules |
| Lange, Dirk | Faculty (G+PS eligible/member) | Ureteral stents; antifouling coatings; antimicrobial coatings; device complications |
| Ma, Hongshen | Faculty (G+PS eligible/member) | Microfluidics; Instrumentation; Cell Sorting; Cell Biomechanics; Circulating Tumor Cells; Malaria and Red Blood Cell Deformability; Single Cell Technologies; Cell Migration and Chemotaxis |
| McMaster, W Robert | Faculty (G+PS eligible/member) | Molecular Immunology |
| Mui, Alice | Faculty (G+PS eligible/member) | Inflammatory Signalling Pathways |
| Nguan, Christopher | Faculty (G+PS eligible/member) | Urology; Computer engineering; Civil engineering, n.e.c.; Biomedical instrumentation (including diagnostics); Medical devices; Artificial tissues engineering; Biomedical robotics; Image guided surgery systems; Applied immunology (including antibody engineering, xenotransplantation and t-cell therapies); Transplantation immunology; kidney transplantation; patient reported outcomes; medical apps for mobile health; machine learning analytics of medical imaging; machine learning analytics of complex medical data outcomes; Robotics; quality in healthcare; environmental impact of healthcare; Artificial Intelligence in Healthcare |
| Ong, Christopher | Faculty (G+PS eligible/member) | Prostate cancer growth; Treatment resistance; Cell signalling pathways; SEMA3C |
| Overall, Christopher Mark | Faculty (G+PS eligible/member) | Blood research, antiviral immunity |
| Roberts, Morgan | Faculty (non-G+PS member) | Tumour immunology; Applied immunology (including antibody engineering, xenotransplantation and t-cell therapies); Solid cancer tumours; Immunology; Bladder cancer; Immuno-oncology; Sex differences in cancer immunobiology |
| Rohling, Robert | Faculty (G+PS eligible/member) | Electrical engineering, computer engineering, and information engineering; Medical biotechnology; ultrasound; Robotics |
| Salcudean, Tim | Faculty (G+PS eligible/member) | Biomedical technologies, Haptic interfaces, teleoperation and simulators, medical robotics, imaging and interfaces, optimization-based design, prostate cancer |
| Somasekharan, Syam | Faculty (G+PS eligible/member) | Cancer, n.e.c.; Cell biology, n.e.c.; RNA Biology; Cell Biology; molecular biology; Biomolecular Condensates; Nucleolus; mRNA Translation; Liquid-liquid Phase Separation |
| Sorensen, Poul | Faculty (G+PS eligible/member) | Childhood cancer cells, genomic science |
| Wang, Yuzhuo | Faculty (G+PS eligible/member) | Clinical oncology; Prostate Cancer; Modeling the Progression of Castration-Resistant Prostate Cancer; Tumor dormancy; Anti-Cancer Drug Development |
| Wyatt, Alexander | Faculty (G+PS eligible/member) | Medical, health and life sciences; Prostate Cancer; Circulating tumour DNA (ctDNA); Bladder cancer; Precision oncology; Clinical trials; Bioinformatics; Cancer Genomics; Cell-Free DNA (cfDNA); Correlative science; Liquid biopsy |
| Zoubeidi, Amina | Faculty (G+PS eligible/member) | Drug resistance in prostate cancer, androgen receptor activity, phenotypic plasticity, enzalutamide |